biotech · Locally Advanced Breast Cancer (LABC) · Mantle Cell Lymphoma
Beijing Luzhu Biopharmaceutical
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Beijing Luzhu Biopharmaceutical trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Beijing, CN HQ
2 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Beijing, CN
- Employees
- 2
- Programs
- 7
- Drugs
- 5
- Patents
- 0
Beijing Luzhu Biopharmaceutical clinical trials
Registry index of 7 ClinicalTrials.gov studies linked to Beijing Luzhu Biopharmaceutical programs — each row shows trial ID, program name, phase, status, and indication.
Beijing Luzhu Biopharmaceutical trial registry — 7 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Beijing Luzhu Biopharmaceutical.
-
pneumococcal disease prevention — Phase 3
Clinical update -
MCV-ACYW135 Vaccine Group — Phase 3
Clinical update -
ICP-022 — Phase 2
Clinical update -
ICP-022 — Phase 2
Clinical update -
BioTTT001 injection — Phase 1
Clinical update -
Vagus Nerve Stimulation — Phase 1
Clinical update -
YN001 — Phase 1
Clinical update